Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | |
| Operating Expenses | 27,531 | 13,025 | 0 |
| Operating Income | -27,531 | -13,025 | N/A |
| Interest Expense | 0 | 287 | 0 |
| Other Income | -516 | -20 | 0 |
| Pre-tax Income | -28,047 | -13,332 | 0 |
| Net Income Continuous | -28,047 | -13,332 | N/A |
| Net Income | $-28,047 | $-13,332 | $N/A |
| EPS Basic Total Ops | -182.00 | -105.60 | N/A |
| EPS Basic Continuous Ops | -149.54 | -94.05 | N/A |
| EPS Diluted Total Ops | -182.00 | -105.60 | N/A |
| EPS Diluted Continuous Ops | -149.54 | -94.05 | N/A |
| EBITDA(a) | $-26,697 | $-12,530 | $N/A |